SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Stevanato Group (STVN). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Dec 3, 2025

Stevanato Group S.p.A. (STVN) Q3 2025 Earnings Call Transcript

Stevanato Group S.p.A. ( STVN ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Lisa Miles - Chief Communications & Investor Relations Officer Franco Stevanato - CEO & Executive Chairman Marco Dal Lago - Chief Financial Officer Conference Call Participants Lawrence Solow - CJS Securities, Inc. Matthew Larew - William Blair & Company L.L.C.

Seeking Alpha • Nov 7, 2025

Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the third quarter of 2025. Third Quarter 2025 Highlights (comparisons to prior-year period) Revenue increased 9% (11% on a constant currency basis) to €303.2 million. High-value solutions represented a record 49% of total reve.

Business Wire • Nov 6, 2025

Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates

Stevanato Group (STVN) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.13 per share a year ago.

Zacks Investment Research • Nov 6, 2025

Stevanato Group to Participate in Upcoming Investor Conferences

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will participate in two upcoming investor conferences. Monday, November 17, 2025, at 8:40 a.m. ET - The 7th Annual Wolfe Research Healthcare Conference in New York City Wednesday, November 19, 2025, at 11:00 a.m. GMT - The Jefferies Global Heal.

Business Wire • Oct 31, 2025

SDZNY vs. STVN: Which Stock Is the Better Value Option?

Investors interested in Medical - Drugs stocks are likely familiar with Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Oct 31, 2025

Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the third quarter of 2025 on Thursday, November 6, 2025, at 6:30 a.m. (ET). Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (ET) on Thursday, November 6, 2025, to di.

Business Wire • Oct 22, 2025

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced a significant expansion of its drug delivery system manufacturing capacity, further strengthening its global footprint to meet the industry's evolving needs. As part of its footprint optimization plan, the Company recently added a state-of-the-art production s.

Business Wire • Oct 21, 2025

GRFS vs. STVN: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • Oct 10, 2025

Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Stevanato Group S.p.A. (NYSE:STVN ) Bank of America Global Healthcare Conference 2025 September 24, 2025 5:45 AM EDT Company Participants Marco Dal Lago - Chief Financial Officer Conference Call Participants Michael Ryskin - BofA Securities, Research Division Presentation Michael Ryskin BofA Securities, Research Division I'm on the Bank of America Life Science Tools and Diagnostics team based out of New York.

Seeking Alpha • Sep 24, 2025